Terms: = Kidney tumors AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776
55 results:
1. CT features based preoperative predictors of aggressive pathology for clinical T1 solid renal cell carcinoma and the development of nomogram model.
Wang K; Dong L; Li S; Liu Y; Niu Y; Li G
BMC Cancer; 2024 Jan; 24(1):148. PubMed ID: 38291357
[TBL] [Abstract] [Full Text] [Related]
2. Three-dimensional topology-based T-index as an indicator of surgical difficulty of partial nephrectomy in patients with small renal mass.
An D; Jung DC; Lee J; Han K; Lee S; Chang KD; Rha KH
Investig Clin Urol; 2023 Sep; 64(5):448-456. PubMed ID: 37668200
[TBL] [Abstract] [Full Text] [Related]
3. Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Ferro M; Chiujdea S; Vartolomei MD; Bove P; Porreca A; Busetto GM; Del Giudice F; Antonelli A; Foschi N; Racioppi M; Autorino R; Chiancone F; Longo N; Barone B; Crocetto F; Musi G; Luzzago S; Piccinelli ML; Mistretta FA; de Cobelli O; Tataru OS; Hurle R; Liguori G; Borghesi M; Veccia A; Greco F; Schips L; Marchioni M; Lucarelli G; Dutto D; Colucci F; Russo GI; Giudice AL; Montanari E; Boeri L; Simone G; Rosazza M; Livoti S; Gontero P; Soria F
Clin Genitourin Cancer; 2024 Apr; 22(2):27-37. PubMed ID: 37661507
[TBL] [Abstract] [Full Text] [Related]
4. Cost-effectiveness of Trastuzumab Deruxtecan for HER2-low Advanced Breast Cancer in the United States.
Peng Y; Wang L; Peng L; Liu Q; Yi L; Luo X; Li S; Qin S; Wan X; Tan C; Chen G
Clin Ther; 2023 Oct; 45(10):965-972. PubMed ID: 37537015
[TBL] [Abstract] [Full Text] [Related]
5. Factors affecting survival and prognosis in surgically treated patients with spinal metastases arising from renal cell carcinoma.
Lei M; Miao J
BMC Urol; 2023 Jul; 23(1):118. PubMed ID: 37443069
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic value of machine learning-based computed tomography texture analysis for differentiating multiple myeloma from osteolytic metastatic bone lesions in the peripheral skeleton.
Özgül HA; Akin IB; Mutlu U; Balci A
Skeletal Radiol; 2023 Sep; 52(9):1703-1711. PubMed ID: 37014470
[TBL] [Abstract] [Full Text] [Related]
7. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
[TBL] [Abstract] [Full Text] [Related]
8. Analysis of factors associated with postoperative acute kidney injury in patients with colorectal cancer and the development of a risk prediction model: a retrospective study.
Li L; Wan X; Zhang Y; Zhao M; Ren J; Zhang Y
Updates Surg; 2023 Aug; 75(5):1171-1178. PubMed ID: 36892811
[TBL] [Abstract] [Full Text] [Related]
9. Head-to-head comparison of [
Wang G; Li L; Wang J; Zang J; Chen J; Xiao Y; Fan X; Zhu L; Kung HF; Zhu Z
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1499-1509. PubMed ID: 36600099
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic value of tumour contour irregularity on surgical strategies for T1bN0M0 renal cell carcinoma: A multi-institutional study.
Xu P; Zhang S; Cheng J; Cao B; Huang J; Li Y; Lin W; Li H; Chen W; Zhu Y; Jiang S; Hu X; Wu J; Wu Z; Zhou J; Guo J; Cheng J; Wang H
Eur J Radiol; 2023 Feb; 159():110665. PubMed ID: 36566705
[TBL] [Abstract] [Full Text] [Related]
11. FAPα and αSMA mark different subsets of fibroblasts in normal kidney and conventional renal cell carcinoma.
Peterfi L; Yusenko MV; Kovacs G; Beothe T
Neoplasia; 2023 Jan; 35():100854. PubMed ID: 36516488
[TBL] [Abstract] [Full Text] [Related]
12. CT radiomics for differentiating oncocytoma from renal cell carcinomas: Systematic review and meta-analysis.
Dehghani Firouzabadi F; Gopal N; Homayounieh F; Anari PY; Li X; Ball MW; Jones EC; Samimi S; Turkbey E; Malayeri AA
Clin Imaging; 2023 Feb; 94():9-17. PubMed ID: 36459898
[TBL] [Abstract] [Full Text] [Related]
13. Predicting the probability of malignant pathological type of kidney cancer based on mass size: A retrospective study.
Li J; Li X; Jiang Z; Hu C; Liu J; Huo J; Liu B
Prog Urol; 2022 Oct; 32(12):849-855. PubMed ID: 36068150
[TBL] [Abstract] [Full Text] [Related]
14. [Establishment of a mutation prediction model for evaluating the efficacy of immunotherapy in renal carcinoma].
Qin CP; Song YX; Ding MT; Wang F; Lin JX; Yang WB; DU YQ; Li Q; Liu SJ; Xu T
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):663-668. PubMed ID: 35950389
[TBL] [Abstract] [Full Text] [Related]
15. GRAMD1A Is a Biomarker of kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.
Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M
Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689
[TBL] [Abstract] [Full Text] [Related]
16. Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers.
Ujike T; Uemura M; Kato T; Hatano K; Kawashima A; Nagahara A; Fujita K; Imamura R; Nonomura N
Int J Clin Oncol; 2022 Apr; 27(4):774-780. PubMed ID: 35119579
[TBL] [Abstract] [Full Text] [Related]
17. Clinical utility of the Bosniak classification version 2019: Diagnostic value of adding magnetic resonance imaging to computed tomography examination.
Arita Y; Yoshida S; Kwee TC; Edo H; Kufukihara R; Shigeta K; Nagasaka M; Takeshita R; Okamura H; Ueda R; Ishii R; Okuda S; Fujii Y
Eur J Radiol; 2022 Mar; 148():110163. PubMed ID: 35066340
[TBL] [Abstract] [Full Text] [Related]
18. A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma.
Gui CP; Wei JH; Chen YH; Fu LM; Tang YM; Cao JZ; Chen W; Luo JH
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34237133
[TBL] [Abstract] [Full Text] [Related]
19. CT-based multi-phase Radiomic models for differentiating clear cell renal cell carcinoma.
Chen M; Yin F; Yu Y; Zhang H; Wen G
Cancer Imaging; 2021 Jun; 21(1):42. PubMed ID: 34162442
[TBL] [Abstract] [Full Text] [Related]
20. Cancer Stage, Treatment, and Survival Among Transgender Patients in the United States.
Jackson SS; Han X; Mao Z; Nogueira L; Suneja G; Jemal A; Shiels MS
J Natl Cancer Inst; 2021 Sep; 113(9):1221-1227. PubMed ID: 33704460
[TBL] [Abstract] [Full Text] [Related]
[Next]
